Strengths

● The company's share price in relation to its net book value makes it look relatively cheap.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.